Evidence map›Paper›PMID 35011007›Full record

ArticleNutrients2021

Korean Red Ginseng Enhances Immunotherapeutic Effects of NK Cells via Eosinophils in Metastatic Liver Cancer Model.

Hee Jung Kwon, Sunyi Lee, Hwan Hee Lee, Hyosun Cho, Joohee Jung

Abstract read
In one paragraph

Article in Nutrients, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Elucidating the role of S100A10 in CD8Cell death & disease · 2024
    Article
  5. Article
  6. Article
  7. Cancer biology & therapy · 2023
    Article
  8. Review
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hee Jung KwonDepartment of Pharmacy, College of Pharmacy, Duksung Women's University, Seoul 01369, Korea.
Sunyi LeeDuksung Innovative Drug Center, Duksung Women's University, Seoul 01369, Korea.ORCID 0000-0003-0783-0480
Hwan Hee LeeDuksung Innovative Drug Center, Duksung Women's University, Seoul 01369, Korea.
Hyosun ChoDepartment of Pharmacy, College of Pharmacy, Duksung Women's University, Seoul 01369, Korea.
Joohee JungDepartment of Pharmacy, College of Pharmacy, Duksung Women's University, Seoul 01369, Korea.ORCID 0000-0001-9124-9052

Funding

NRF grant funded by MSIT 2021R1A2C200453511the Priority Research Centers Program through NRF 2016R1A6A1A03007648
6 · The paper itself

Abstract

Metastasis decreases the survival rate of patients with liver cancer. Therefore, novel anti-metastatic strategies are needed. Korean Red Ginseng (KRG) is often ingested as a functional food with an immune-boosting effect. We investigated a combination of KRG and natural killer (NK) cells as a novel immunotherapy approach. SK-Hep1 cells were injected into the tail vein of NRGA mice to establish an experimental metastasis model. KRG, NK cells, or a combination of KRG and NK cells were administered. Tumor growth was observed using an in vivo imaging system, and metastatic lesions were evaluated by histological analysis and immunohistochemistry. Bioluminescence intensity was lower in the KRG and NK cell combination group than in the other groups, indicating that the combination treatment suppressed the progression of metastasis. CD56 expression was used as a NK cell marker and hematological analysis was performed. The combination treatment also decreased the expression of matrix metalloproteinases and the area of metastatic lesions in liver and bone tissues, as well as increased the eosinophil count. Expression of cytokines-related eosinophils and NK cells was determined by Western blotting analysis. The expression of interleukin 33 (IL33) was induced by the combination of KRG and NK cells. High IL33 expression was associated with prolonged overall survival in the Kaplan-Meier plotter. Our results suggest that KRG enhances the immune activity of NK cells by IL-33 through eosinophils and suppresses metastatic liver cancer progression.

Indexed as

PanaxAnimalsDisease Models, AnimalEosinophilsImmunotherapyInterleukin-33Killer Cells, NaturalLiver NeoplasmsMiceNeoplasm MetastasisPlant ExtractsSurvival AnalysisIl33 protein, mouseInterleukin-33Plant ExtractseosinophilIL33Korean Red Ginsengmetastatic liver cancernatural killer cell

Identifiers

PMID35011007
PMCPMC8747263

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.